tirzepatide alternative Eli Lilly sues companies selling versions of its weight loss drug : Shots What are alternative medications to

To compete with the upcoming generics, Novo Nordisk received Health Canada approval on December 22, 2025, for two new branded products, Plosbrio and Poviztra

All prescription products require an online evaluation with an independent, licensed medical professional who will determine if a prescription is appropriate

2022;42(3):BSR20212209

The purpose of this gradual increase is to: Reduce gastrointestinal side effects Allow the body to adapt to GLP-1 activity Improve long-term adherence to treatment Maximize fat loss results safely Patients who follow the correct dosing schedule are significantly more likely to achieve sustainable weight loss results compared to those who skip steps or increase dosage too quickly